Piramal Pharma Ltd.

•

piramalpharma.comBSE: 543635NSE: PPLPHARMA

Market Cap₹ 29,037 Cr.

Current Price

High / Low₹ 232 / 132

Stock P/E41.5

Book Value₹ 61

Price to Book2.25

Dividend Yield0.00 %

ROCE10.9 %

ROE9.1 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.25x)
Company comfortably covers its interest (12.0x coverage)
Attractively priced for its growth - PEG of 0.4

CONS

A large part of profit comes from other income (77.4% of PBT)
Company has a low return on equity of 8.5% over last 3 years
Company has a low return on capital employed of 10.6%
Working capital days have increased from 82 to 119 days
Company has delivered a poor profit growth of 4.1% over past five years
Equity base is being diluted - shares outstanding up 11.2%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY PHARMA NIFTY TOTAL MKT NIFTY SMLCAP 50 NIFTY 500 NIFTY SMLCAP 250

S.No.	Name
1.	SUNPHARMA	1868.50	37.06	448315.74	0.86	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9482.75	86.06	251737.22	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4931.90	86.01	187593.62	0.77	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1129.00	24.95	112618.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1368.00	32.79	110515.04	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1933.25	95.54	104455.86	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	AUROPHARMA	1690.00	26.19	97238.86	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
8.	LUPIN	2092.00	17.30	95660.02	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
9.	DRREDDY	1143.20	29.61	95420.61	0.70	435.60	-69.10	8099.80	-5.21	13.75	10.63
10.	MANKIND	2266.00	45.82	93596.02	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2439.55	38.29	68850.12	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	PPLPHARMA	218.10	41.46	29036.70	0.00	-69.39	15.07	2269.92	17.39	1.24	9.46

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	846	994	1,024	1,525	1,063	1,284	1,248	1,690	970	1,127	1,196	1,489	1,125
	830	908	899	1,136	912	1,032	1,029	1,273	926	1,000	1,029	1,186	1,090
Operating Profit	17	86	126	390	152	253	219	417	44	127	167	303	35
OPM %	1.96%	8.67%	12.26%	25.55%	14.26%	19.69%	17.57%	24.65%	4.57%	11.27%	13.99%	20.37%	3.10%
	27	89	33	53	37	106	25	40	181	202	69	118	115
Interest	34	28	17	28	25	30	29	31	23	20	17	20	16
Depreciation	50	51	52	52	52	54	55	61	59	61	65	70	66
Profit before Tax	-41	96	90	363	112	276	159	364	143	247	155	332	149
Tax %	18.44%	19.78%	17.09%	24.70%	23.63%	23.81%	25.48%	23.90%	20.65%	20.65%	16.79%	21.16%	24.08%
Net Profit	-33	77	74	273	85	210	119	277	113	196	129	262	113
	-0.27	0.61	0.56	2.06	0.64	1.59	0.90	2.09	0.85	1.48	0.97	1.97	0.85

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	2,939	3,340	3,443	4,390	5,286	4,782	4,937
	2,320	2,865	3,346	3,791	4,277	4,156	4,305
Operating Profit	619	475	98	599	1,009	626	633
OPM %	21.06%	14.23%	2.83%	13.65%	19.09%	13.09%	12.81%
	216	210	334	221	239	586	504
Interest	5	57	116	107	115	80	73
Depreciation	144	165	192	205	222	256	262
Profit before Tax	687	462	124	508	911	877	884
Tax %	16.79%	20.50%	43.81%	22.93%	24.12%	20.16%	20.75%
Net Profit	572	368	70	391	691	700	700
EPS	9.11	3.12	0.57	2.96	5.22	5.27	—
Dividend Payout %	0.00%	0.00%	0.00%	3.72%	2.68%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 10%
3 Years:: 12%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: 4%
3 Years:: 116%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: 26%
1 Year:: 7%

RETURN ON EQUITY

10 Years:: —
5 Years:: 7%
3 Years:: 8%
Last Year:: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	995	1,186	1,193	1,323	1,324	1,327
	3,106	3,937	4,068	5,362	6,065	6,739
	173	876	1,335	914	1,023	482
Trade Payables	584	647	762	1,108	1,185	2,011
	995	934	938	1,173	1,361	1,750
Total Liabilities	5,852	7,579	8,296	9,879	10,958	12,310
	1,627	2,439	2,602	2,612	2,894	3,036
Capital Work in Progress	79	157	136	232	78	102
	1,592	1,630	1,747	1,708	3,105	3,580
	421	536	819	1,153	1,205	1,873
	0	0	0	1,331	1,667	1,406
Cash & Bank	152	137	64	242	178	574
	1,981	2,681	2,928	2,600	1,831	1,739
Total Assets	5,852	7,579	8,296	9,879	10,958	12,310

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	130	352	132	358	549	1,328
Cash from Investing	-4,383	-1,246	-435	-636	-550	-318
Cash from Financing	4,494	896	290	451	-62	-615
	146	-100	-73	174	-63	395

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	34.95	34.95	34.95	34.95	34.86	34.86	34.86	34.86	34.80
	31.41	31.73	31.68	31.49	30.86	30.27	29.66	30.17	12.51
	12.95	13.80	14.09	14.78	14.25	14.89	15.69	15.61	14.57
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	20.69	19.52	19.27	18.78	20.03	19.98	19.79	19.36	38.11

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-08

Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-08 - Intimation of Schedule of Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

2026-09-03

General Updates

2026-09-03 - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - ESG Rating

2026-08-24

Updates

2026-08-24 - Sustainability Report of Piramal Pharma Limited ( the Company ) for thefinancial year 2025-26-26

2026-08-18

Acquisition

2026-08-18 - Piramal Pharma Limited has informed the Exchange about Acquisition

2026-08-10

Updates

2026-08-10 - Piramal Pharma Limited has informed the Exchange regarding 'Exercise of call option for acquisition of additional equity stake in Yapan Bio PrivateLimited'.

2026-08-10

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-10 - Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

2026-08-03

Updates

2026-08-03 - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Resumption of operations at Company s facilities located at Ahmedabad, Gujarat

2026-07-31

Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-31 - Piramal Pharma Limited has informed the Exchange about Transcript

2026-07-30

Shareholders meeting

2026-07-30 - Proceedings and Voting Results of the 6th Annual General Meeting of the Company

News

Recent coverage and analyst commentary for PPLPHARMA

Loading news…

🤖

AI Stock Analyst

Piramal Pharma Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1868.50

37.06

448315.74

0.86

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9482.75

86.06

251737.22

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4931.90

86.01

187593.62

0.77

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1129.00

24.95

112618.18

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1368.00

32.79

110515.04

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1933.25

95.54

104455.86

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

AUROPHARMA

1690.00

26.19

97238.86

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2092.00

17.30

95660.02

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

DRREDDY

1143.20

29.61

95420.61

0.70

435.60

-69.10

8099.80

-5.21

13.75

10.63

MANKIND

2266.00

45.82

93596.02

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2439.55

38.29

68850.12

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

PPLPHARMA

218.10

41.46

29036.70

0.00

-69.39

15.07

2269.92

17.39

1.24

9.46

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

846

994

1,024

1,525

1,063

1,284

1,248

1,690

970

1,127

1,196

1,489

1,125

830

908

899

1,136

912

1,032

1,029

1,273

926

1,000

1,029

1,186

1,090

Operating Profit

126

390

152

253

219

417

127

167

303

OPM %

1.96%

8.67%

12.26%

25.55%

14.26%

19.69%

17.57%

24.65%

4.57%

11.27%

13.99%

20.37%

3.10%

106

181

202

118

115

Interest

Depreciation

Profit before Tax

-41

363

112

276

159

364

143

247

155

332

149

Tax %

18.44%

19.78%

17.09%

24.70%

23.63%

23.81%

25.48%

23.90%

20.65%

16.79%

21.16%

24.08%

Net Profit

-33

273

210

119

277

113

196

129

262

113

-0.27

0.61

0.56

2.06

0.64

1.59

0.90

2.09

0.85

1.48

0.97

1.97

0.85

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

2,939

3,340

3,443

4,390

5,286

4,782

4,937

2,320

2,865

3,346

3,791

4,277

4,156

4,305

Operating Profit

619

475

599

1,009

626

633

OPM %

21.06%

14.23%

2.83%

13.65%

19.09%

13.09%

12.81%

216

210

334

221

239

586

504

Interest

116

107

115

Depreciation

144

165

192

205

222

256

262

Profit before Tax

687

462

124

508

911

877

884

Tax %

16.79%

20.50%

43.81%

22.93%

24.12%

20.16%

20.75%

Net Profit

572

368

391

691

700

EPS

9.11

3.12

0.57

2.96

5.22

5.27

—

Dividend Payout %

0.00%

3.72%

2.68%

0.00%

—

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

995

1,186

1,193

1,323

1,324

1,327

3,106

3,937

4,068

5,362

6,065

6,739

173

876

1,335

914

1,023

482

Trade Payables

584

647

762

1,108

1,185

2,011

995

934

938

1,173

1,361

1,750

Total Liabilities

5,852

7,579

8,296

9,879

10,958

12,310

1,627

2,439

2,602

2,612

2,894

3,036

Capital Work in Progress

157

136

232

102

1,592

1,630

1,747

1,708

3,105

3,580

421

536

819

1,153

1,205

1,873

1,331

1,667

1,406

Cash & Bank

152

137

242

178

574

1,981

2,681

2,928

2,600

1,831

1,739

Total Assets

5,852

7,579

8,296

9,879

10,958

12,310

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

130

352

132

358

549

1,328

Cash from Investing

-4,383

-1,246

-435

-636

-550

-318

Cash from Financing

4,494

896

290

451

-62

-615

146

-100

-73

174

-63

395

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

34.95

34.86

34.80

31.41

31.73

31.68

31.49

30.86

30.27

29.66

30.17

12.51

12.95

13.80

14.09

14.78

14.25

14.89

15.69

15.61

14.57

Government

0.00

20.69

19.52

19.27

18.78

20.03

19.98

19.79

19.36

38.11

Piramal Pharma Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Piramal Pharma Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI